Home > Balance Sheet > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹13 Cr₹11 Cr₹7.94 Cr₹6.46 Cr₹5.69 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of LINCOLN PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of LINCOLN PHARMACEUTICALS is ₹13 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹13 Cr
Mar2024₹11 Cr
Mar2023₹7.94 Cr
Mar2022₹6.46 Cr
Mar2021₹5.69 Cr

How is Deferred Tax Assets / Liabilities of LINCOLN PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹13 Cr
13.50
Mar2024 ₹11 Cr
44.26
Mar2023 ₹7.94 Cr
23.02
Mar2022 ₹6.46 Cr
13.42
Mar2021 ₹5.69 Cr -

Compare Deferred Tax Assets / Liabilities of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,270.2 Cr 3.5% 37.6% -7.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr 1.6% 4.6% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 3.1% 5.9% 39% Stock Analytics
CIPLA ₹108,978.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 0.5% 9.8% 5.7% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

3.5%

37.6%

-7.4%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses